Use of cytokines, cells and mitogens to inhibit graft versus host disease
US6803036B1 · kind B1 · utility
15Cited by
4References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 1, 2000 |
| Grant date | Oct 12, 2004 |
| Priority date | — |
| Expiry date | May 4, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/599
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The field of the invention is generally related to pharmaceutical agents useful in treating graft-versus-host disease (GVHD) in patients that have received allogenic bone marrow transplants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.